Page 6 - Britain Eakin News Today

A Federal Circuit panel seemed skeptical Tuesday that Gilead Sciences and Astellas were wrongly barred from responding to amendments Hospira made "at the eleventh hour" to an abbreviated new drug application to skirt infringement of patents on cardiac stress agent Lexiscan.

A begrudging California federal judge is giving a Mexican restaurant another shot at a proposed Lanham Act class action against Google, but warned the restaurant's attorneys that sanctions could be on the horizon over misleading evidence in the first amended complaint.

In the latest installment of the battle over who invented gene editing technology CRISPR first, chemical giant Sigma-Aldrich urged the Patent Trial and Appeal Board on Monday to recognize that its contribution to the field sets it apart.

The Federal Circuit on Wednesday backed the claim construction behind the Patent Trial and Appeal Board's invalidation of three CUPP Computing cybersecurity patents in challenges from Trend Micro, clarifying that disclaimers made during inter partes reviews only apply in subsequent proceedings.

A federal jury in the Western District of Texas on Tuesday hit Intel Corp. with a nearly $949 million verdict for infringing a VLSI patent for microchip technology, handing the patent licensing company another whopping verdict in its ongoing fight with the chipmaker.

A federal jury in the Western District of Texas on Tuesday hit Intel Corp. with a nearly $949 million verdict for infringing a VLSI patent for microchip technology, handing the patent licensing company another whopping verdict in its ongoing fight with the chipmaker.

The fourth round of a multibillion-dollar dispute between Intel and VLSI over the licensing company's microchip technology patents got underway Monday in Austin, Texas, repeating themes attorneys raised in April during an earlier trial that was thwarted by COVID-19.

The chief judge of the Federal Circuit practically begged members of the American Intellectual Property Law Association on Thursday to put their efforts into educating the public on the U.S. patent system, especially as it relates to pharmaceuticals.

U.S. Patent and Trademark Office Director Kathi Vidal said Thursday that while she thinks the U.S. intellectual property system is working pretty well, the clamoring that sometimes erupts with pushes to change the system isn't helping matters.

The Patent Trial and Appeal Board has rejected dual challenges to two cataract surgery patents owned by a Johnson & Johnson unit, determining that Alcon Inc. failed to show any of the claims across the two patents are invalid.